Provided by Tiger Trade Technology Pte. Ltd.

Technipfmc Plc

76.34
+0.76001.01%
Post-market: 76.340.00000.00%19:30 EDT
Volume:2.55M
Turnover:193.03M
Market Cap:29.94B
PE:26.65
High:76.53
Open:76.07
Low:74.23
Close:75.58
52wk High:80.70
52wk Low:35.29
Shares:392.16M
Float Shares:386.00M
Volume Ratio:0.95
T/O Rate:0.66%
Dividend:0.20
Dividend Rate:0.26%
EPS(TTM):2.86
EPS(LYR):2.30
ROE:35.81%
ROA:9.53%
PB:9.15
PE(LYR):33.19

Loading ...

FTI Consulting announces additional $370M share repurchase authorization

TIPRANKS
·
Jun 05

TechnipFMC price target raised to $80 from $75 at Goldman Sachs

TIPRANKS
·
Jun 04

TechnipFMC PLC Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jun 04

Analysts’ Opinions Are Mixed on These Energy Stocks: Oneok (OKE) and TechnipFMC (FTI)

TIPRANKS
·
Jun 03

Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy

GlobeNewswire
·
Jun 03

TechnipFMC PLC Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 03

TechnipFMC files Form 3 for director Eric D. Mullins

Reuters
·
Jun 03

TechnipFMC appoints Lime Rock Resources CEO Eric Mullins to board

Reuters
·
Jun 02

TechnipFMC Appoints Eric D. Mullins to Its Board of Directors

THOMSON REUTERS
·
Jun 02

Treasury announces $1.05M settlement with FTI Consulting

TIPRANKS
·
Jun 02

A Look At TechnipFMC (FTI) Valuation After A Strong Multi Year Shareholder Return

Simply Wall St.
·
Jun 01

TechnipFMC price target raised to $85 from $53 at Jefferies

TIPRANKS
·
May 31

TechnipFMC PLC Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
May 30

TechnipFMC PLC Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
May 28

TechnipFMC Down Nearly 6%, on Pace for Largest Percent Decrease Since April 2025 -- Data Talk

Dow Jones
·
May 28

Movement Alert|TechnipFMC Falls 6.06% in Regular Trading, Trading at $67.06

Market Focus
·
May 28

Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors

GlobeNewswire
·
May 26

TechnipFMC PLC Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
May 22

TechnipFMC CEO Pferdehirt speaks at Bernstein Strategic Decisions Conference

Reuters
·
May 22

TechnipFMC to Speak at Bernstein 42Nd Annual Strategic Decisions Conference

THOMSON REUTERS
·
May 22